Paul Tudor Jones’s Athenahealth, Inc. ATHN Stock Holding History

Paul Tudor Jones’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-200,000	Closed	-$21.7M	–	1404
2013 Q3	$21.7M	Buy	+200,000	New	+$21.6M	0.89%	14

Other funds holding ATHN

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Paul Tudor Jones's ATHN Position: Q2 2018 in Review

Paul Tudor Jones sold out of Athenahealth, Inc. (ATHN) in Q2 2018, closing a stake of 11,612 shares — an estimated $1.66M sold.

Paul Tudor Jones first reported a position in ATHN in Q1 2016 and held it in 7 quarters. The position peaked at $1.66M in Q1 2018. 275 funds tracked by Wall St. Rank hold ATHN as of Q2 2018.

Paul Tudor Jones reported no remaining Athenahealth, Inc. position as of Q2 2018 after selling out during the quarter.
Paul Tudor Jones sold 11,612 Athenahealth, Inc. shares in Q2 2018, an estimated $1.66M.
Paul Tudor Jones first reported a position in Athenahealth, Inc. in Q1 2016 and held it in 7 quarters.
Paul Tudor Jones's Athenahealth, Inc. position peaked at $1.66M in Q1 2018.
275 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q2 2018.

Based on Tudor Investment Corp's 13F filing for Q2 2018, filed 14 Aug 2018.